We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Comen Medical

Download Mobile App

Image: First-in-Class Nasal Spray Could Both Treat and Prevent COVID-19 (Photo courtesy of ENA Respiratory)

First-in-Class Nasal Spray Could Both Treat and Prevent COVID-19

A first-in-class nasal spray is being developed for the treatment as well as prevention of COVID-19 and other respiratory viral infections. More...
17 Jun 2021

AI-Enhanced EKG Can Be Used as Rapid, Reliable COVID-19 Screening Test to Rule out Infection

Artificial intelligence (AI) may offer a way to accurately determine that a person is not infected with COVID-19. More...
16 Jun 2021

Getinge's AI Solution Helps Hospitals Address Post COVID-19 Pandemic Surgical Backlog

A new artificial intelligence solution is designed to improve efficiency in managing schedules for surgical procedures, helping to address the post COVID-19 pandemic surgical backlog. More...
11 Jun 2021

Oral COVID-19 Vaccine Proves an Effective Booster in Preclinical Trial

An oral subunit vaccine against COVID-19 has demonstrated promising results as a booster for previously vaccinated persons in preclinical tests. More...
11 Jun 2021

Engineered IgM Antibody Administered Intranasally May Be More Potent at Inhibiting SARS-CoV-2 and Its Variants than Current Antibody Therapies

An IgM version of an anti-SARS-CoV-2 IgG monoclonal antibody is being developed as an intranasally administered agent for the treatment and prevention of COVID-19. More...
10 Jun 2021
Image: A scanning electron microscope image showing SARS-CoV-2 (round gold objects), the virus that causes COVID-19, emerging from the surface of cells cultured in the lab (Photo courtesy of NIAID)

Experimental Drug TEMPOL May Be Promising Oral Antiviral Treatment for COVID-19, Suggests New Research

The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19 and can limit SARS-CoV-2 infection by impairing the activity of a viral enzyme called “RNA replicase,” according to a new study of cell cultures. More...
07 Jun 2021

Next-Generation COVID-19 Antibody to Neutralize SARS-CoV-2 Mutated Variants and Allow Injectable Dosing

A SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic has been engineered to broadly neutralize the mutated emerging coronavirus variants, with demonstrated broad-spectrum reactivity against 99.5% of all coronavirus variants in the US and over 98% of coronavirus variants globally. More...
07 Jun 2021
Copyright © 2000-2021 Globetech Media. All rights reserved.